Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

Rhea-AI Summary

Organogenesis (Nasdaq: ORGO) will report second quarter fiscal 2026 financial results after market close on Thursday, August 6, 2026. Management will host a 5:00 p.m. ET conference call and live webcast, including a corporate update and Q&A session.

The webcast will be available at investors.organogenesis.com and archived for about one year.

News Market Reaction – ORGO

-0.40%

1 alert

-0.40% Session close to close

$317.83M Market Cap

0.1x Rel. Volume

In the Jul 9 session, ORGO declined 0.40%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The key development is formal scheduling of Q2 FY 2026 results and a post-close call on August 6, 20...

Analysis

The key development is formal scheduling of Q2 FY 2026 results and a post-close call on August 6, 2026. With recent quarters showing significant volatility in fundamentals, investors may focus on whether trends stabilize while short interest remains elevated.

Key Figures

Earnings period: Second quarter fiscal 2026 Earnings release date: August 6, 2026 Conference call time: 5:00 p.m. Eastern Time +1 more

4 metrics

Earnings period Second quarter fiscal 2026 Results to be reported August 6, 2026

Earnings release date August 6, 2026 Q2 FY 2026 results after market close

Conference call time 5:00 p.m. Eastern Time Management call on August 6, 2026

Webcast archive duration Approximately one year Earnings call replay on company website

Previous Earnings date Reports

2 past events · Latest: Apr 06 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 06	Earnings date notice	Neutral	+0.0%	Announced Q1 2026 earnings release timing and 5:00 p.m. ET conference call.
Feb 19	Earnings date notice	Neutral	+0.3%	Set Q4 and FY 2025 earnings release date and post-close conference call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent earnings-date notices for this stock have produced very small share-price reactions, implying scheduling updates alone have not been strong trading catalysts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CANTON, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care, and surgical and sports medicine markets, today announced that second quarter of fiscal year 2026 financial results will be reported after the market closes on Thursday, August 6th.

Management will host a conference call at 5:00 p.m. Eastern Time on August 6th to discuss the results of the quarter, and to provide a corporate update with a question and answer session. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.organogenesis.com. The webcast will be archived on the company website for approximately one year.

About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com.

Investor Inquiries:
ICR Healthcare
Mike Piccinino, CFA
OrganoIR@icrinc.com

Press and Media Inquiries:
Organogenesis
communications@organo.com

FAQ

When will Organogenesis (ORGO) report Q2 fiscal 2026 financial results?

Organogenesis will report second quarter fiscal 2026 financial results after the market closes on Thursday, August 6, 2026. According to Organogenesis, the release will be followed by a management conference call and webcast at 5:00 p.m. Eastern Time.

What time is the Organogenesis (ORGO) Q2 2026 earnings conference call on August 6, 2026?

The Organogenesis Q2 fiscal 2026 conference call is scheduled for 5:00 p.m. Eastern Time on August 6, 2026. According to Organogenesis, management will discuss quarterly results, provide a corporate update, and host a question and answer session.

How can investors access the Organogenesis (ORGO) Q2 2026 earnings webcast?

Investors can access the Organogenesis Q2 2026 live webcast via links provided for the event and through investors.organogenesis.com. According to Organogenesis, both the webcast and a teleconference option will be available for participants on August 6, 2026.

Will the Organogenesis (ORGO) Q2 2026 earnings webcast be available for replay?

Yes, the Organogenesis Q2 2026 earnings webcast will be archived on the company website. According to Organogenesis, the archived webcast will remain accessible at investors.organogenesis.com for approximately one year after the live event.

What will be covered during the Organogenesis (ORGO) Q2 2026 earnings call?

The Organogenesis Q2 2026 earnings call will cover quarterly financial results and a corporate update. According to Organogenesis, management will also host a question and answer session as part of the 5:00 p.m. Eastern Time conference call.

Where is Organogenesis (ORGO) traded and what markets does it serve?

Organogenesis trades on Nasdaq under the ticker symbol ORGO. According to Organogenesis, the company develops, manufactures, and sells regenerative medicine and tissue innovation products for advanced wound care, surgical markets, and sports medicine applications.